|
|
|
|
| LEADER |
01776nam a2200265 u 4500 |
| 001 |
EB002072127 |
| 003 |
EBX01000000000000001212217 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220923 r ||| eng |
| 020 |
|
|
|a 9789240030824
|
| 020 |
|
|
|a 9789240030831
|
| 245 |
0 |
0 |
|a WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
|h Elektronische Ressource
|
| 246 |
3 |
1 |
|a Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
|
| 250 |
|
|
|a Second edition
|
| 260 |
|
|
|a Geneva
|b World Health Organization
|c 2021, [2021]
|
| 300 |
|
|
|a 1 PDF file (xvi, 97 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographic references
|
| 710 |
2 |
|
|a World Health Organization
|
| 710 |
2 |
|
|a Special Programme of Research, Development, and Research Training in Human Reproduction (World Health Organization)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK572317
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO's recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements. 1. Among the 23 recommendations, 6 are identical for both the general population of women and for women living with HIV and 12 are different and specific for each population.2. Among the 7 good practice statements, 3 are identical for both the general population of women and for women living with HIV and 2 are different and specific for each population
|